Presentation and Outcome of Tuberculous Meningitis in a High HIV Prevalence Setting

• Suzaan Marais ,

  * E-mail: suzaanmarais@gmail.com

  Affiliations Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Infectious Diseases Unit, GF Jooste Hospital, Cape Town, South Africa, Department of Medicine, University of Cape Town, Cape Town, South Africa

  ⨯
• Dominique J. Pepper,

  Affiliations Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Department of Internal Medicine, University of Mississippi Medical Center, Jackson, Mississippi, United States of America

  ⨯
• Charlotte Schutz,

  Affiliations Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Infectious Diseases Unit, GF Jooste Hospital, Cape Town, South Africa, Department of Medicine, University of Cape Town, Cape Town, South Africa

  ⨯
• Robert J. Wilkinson,

  Affiliations Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Infectious Diseases Unit, GF Jooste Hospital, Cape Town, South Africa, Department of Medicine, University of Cape Town, Cape Town, South Africa, Division of Medicine, Imperial College London, London, United Kingdom, Division of Mycobacterial Research, MRC National Institute for Medical Research, London, United Kingdom

  ⨯
• Graeme Meintjes

  Affiliations Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Infectious Diseases Unit, GF Jooste Hospital, Cape Town, South Africa, Department of Medicine, University of Cape Town, Cape Town, South Africa, Division of Medicine, Imperial College London, London, United Kingdom

  ⨯